The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease

Charytan, D., Kuntz, R.E.·2006·Kidney International
DOI 10.1038/sj.ki.5001934

Cited by (271)

Items 201–271 of 271

  1. Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE
    Kamal Gupta, Harsh Mehta, Hwasoon Kim, Amanda Stebbins, Lisa Miller Wruck, Daniel Muñoz, Mark B. Effron, R. David Anderson, Carl J. Pepine, Sandeep K Jain et al. · 2023 · American Heart Journal
  2. Management Considerations for Acute Coronary Syndromes in Chronic Kidney Disease
    Matthew Ian Tomey, Janice Y. Chyou · 2024 · Current Cardiology Reports
  3. Antithrombotic Therapy in Acute Coronary Syndrome Patients with End-Stage Renal Disease: Navigating Efficacy and Safety
    Tarek Abdeldayem, Visvesh Jeyalan, Afzal Hayat, Saif Memon, Mohamed Farag, Mohaned Egred · 2025 · Journal of Clinical Medicine
  4. Sex Differences in Coronary Revascularization Strategies and Outcomes in Patients Undergoing Dialysis
    Silvi Shah, Annette L. Christianson, Pragati Basera, Anthony C. Leonard, Deidra C. Crews, Jack Rubinstein, Mark M. Mitsnefes, Daniel P. Schauer, Charuhas V. Thakar · 2025 · Clinical Journal of the American Society of Nephrology
  5. Acute kidney injury and multivessel percutaneous coronary interventions in chronic renal disease: the AMICI study
    Alessandro Sciahbasi, Andrea Cuono, Alberto Marrangoni, Francesco Perone, Giacomo Nucci, Vanessa Porretta, Nunzia Borrelli, Silvio Fedele, Silvio Romano, Massimo Di Marco et al. · 2020 · Minerva Cardiology and Angiology
  6. Chronic Kidney Disease and Third‐Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year
    Antonio Tello‐Montoliu, Juan M. Ruiz-Nodar, María Asunción Esteve‐Pastor, Andrea Veliz-Martínez, Esteban Orenes‐Piñero, M J Macias-Villanego, Teresa Lozano, Luna Carrillo-Alemán, Nuria Vicente‐Ibarra, Vicente Pernias-Escrig et al. · 2018 · The Journal of Clinical Pharmacology
  7. Prophylactic hemodialysis following coronary angiography and one-year outcomes in non-dialysis patients with chronic kidney disease: A propensity-matched study
    Hsin-Yu Chen, Shih‐Hsiang Ou, Kang-Ju Chou, Hua-Chang Fang, Chien‐Liang Chen, Chih‐Yang Hsu, Chien‐Wei Huang, Chung Chang, Po‐Tsang Lee, Cheng‐Hsu Yang · 2020 · Journal of the Formosan Medical Association
  8. A retrospective study of antithrombotic therapy use in an outpatient haemodialysis unit
    Kaye Dizon, Patrick Ng, Marisa Battistella · 2021 · Journal of Clinical Pharmacy and Therapeutics
  9. Statin Treatment Intensity, Discontinuation, and Long-Term Outcome in Patients With Acute Myocardial Infarction and Impaired Kidney Function
    Masih Khedri, Karolina Elisabeth Szummer, Pia Lundman, Tomas Jernberg, Liyew Desta, Bertil Lindahl, David Erlinge, Stefan H. Jacobson, Jonas Spaak · 2023 · Journal of Cardiovascular Pharmacology
  10. Spironolactone in Dialysis: What’s Old Is New Again
    David M. Charytan · 2016 · American Journal of Kidney Diseases
  11. Complete surgical myocardial revascularization in patients with declined renal functions: 12-month outcomes
    İbrahim Çağrı Kaya, Halil Bulut, Leilani Lopes, Merih Özbayburtlu, Alper Selim Kocaoğlu · 2023 · BMC Cardiovascular Disorders
  12. Cardiac Catheterization in the Dialysis Population in 2012: We Know More, but Much Remains Unknown
    Salvatore P. Costa, John E. Jayne, Scott E. Friedman, Krista L. Lentine · 2012 · Seminars in Dialysis
  13. La insuficiencia renal crónica se asocia a un peor pronóstico tras implante de stent liberador de sirolimus
    Diego López‐Otero, María Bastos Fernández, María Alvarez Barredo, Ramiro Trillo, Pablo Souto-Castro, Belén Cid Álvarez, Maria Elena Dominguez Tourino, José Ramón González‐Juanatey · 2010 · Medicina Clínica
  14. Revascularización miocárdica en pacientes con insuficiencia renal crónica
    D. López Otero, Pablo Souto-Castro, Ramiro Trillo, José Ramón González‐Juanatey · 2009 · Medicina Clínica
  15. The Comparative Safety and Effectiveness of Bivalirudin Versus Heparin Monotherapy in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
    D. Sukul, Milan Seth, T. Schreiber, A. Khandelwal, L. Cannon, Thomas Lalonde, H. Gurm · 2017 · Catheterization and cardiovascular interventions
  16. Chronic kidney disease is a risk factor for cardiovascular disease
    C.R. Swanepoel · 2017 · SA Heart
  17. Cardiovascular Disease and Chronic Kidney Disease
    J. Rangaswami, P. McCullough · 2020 · Chronic Renal Disease
  18. Cardiovascular Disease in Chronic Kidney Disease
    Mark J. Sarnak, Daniel E. Weiner · 2018 · Elsevier eBooks
  19. Renalism with Renin Angiotensin Aldosterone System Blockade: What Is the Consensus in Advanced Chronic Kidney Disease?
    Keila Turino Miranda, Sofia Bano Ahmed · 2024 · Canadian Journal of Cardiology
  20. Long-Term Clinical Outcome of Drug-Eluting vs. Bare-Metal Stent Implantation After Percutaneous Coronary Intervention in End-Stage Renal Disease Patients on Hemodialysis ― Nationwide Cohort Study in Taiwan ―
    Meiling Chen, Jung-Lun Wu, Michael Yu‐Chih Chen, Tsung‐Cheng Hsieh · 2019 · Circulation Journal
  21. Chronic kidney disease and the outcomes of fibrinolysis for ST-segment elevation myocardial infarction: A real-world study
    Wuxiang Xie, Anushka A Patel, Eric H. Boersma, Feng Lin, Min� Li, Runlin Gao, Yangfeng Wu · 2021 · PLoS ONE
  22. Polymer-free biolimus-A9-eluting stent performance according to renal impairment: insights from the RUDI-FREE registry
    Mauro Chiarito, Matteo Sturla, Carlo Briguori, Massimo Mancone, Corrado Tamburino, Franco Fabbiocchi, Daniela Trabattoni, Fabrizio Tomai, Anita Paggi, Gaetano Gioffrè et al. · 2021 · Journal of Cardiovascular Medicine
  23. The Impact of Pre-Procedural Renal Impairment on Outcomes Following Percutaneous Coronary Intervention: An Analysis of 45,287 Patients From the British Columbia Cardiac Registry
    Navin Chandra, Michael David Fryer, Imad J. Nadra, David A. Wood, John G. Webb, Lillian Ding, Sean Hardiman, Anthony Fung, Eve D. Aymong, Albert W. Chan et al. · 2022 · Heart Lung and Circulation
  24. Hemorrhagic Versus Ischemic Risk in Patients with Atrial Fibrillation on Hemodialysis
    Mariana Sousa, Gonçalo Calheiros Cruz, Sara Vilela, Catarina Gouveia Cardoso, Pedro Bravo, José Paulo Marques dos Santos, Cristina García Santos, Jorge A. Silva · 2022 · International Journal of Cardiovascular Sciences
  25. Shades of Grey
    Aisha Khattak, David M. Charytan · 2015 · Clinical Journal of the American Society of Nephrology
  26. A Piece of the Puzzle in the Cardiorenal Conundrum
    Julie Lin · 2013 · Journal of the American Society of Nephrology
  27. Primary percutaneous coronary intervention: different outcome for different subgroups?
    Stefano Savonitto, Carlo Briguori, Flavio Luciano Ribichini, Fabrizio Tomai, Emanuela Piccaluga · 2009 · Journal of Cardiovascular Medicine
  28. Distributed simulation of PCS networks using a Time Warp mechanism
    Roberto Beraldi, S. Marano, Libero Nigro · 1996 · Archive of Doctoral Theses and Digital Collections (University of Calabria)
  29. Clopidogrel in ESRD patients with acute coronary syndrome
    Weekitt Kittisupamongkol · 2009 · Kidney International
  30. The Effect of Antiplatelet Agent on Platelet Function in End-stage Renal Disease
    Dae Yeon Kim, Hee-Soon Park, Dong-Jae Han, Ho Sung Rhee, Tae Woo Kim, Sun Young Jung, Hee‐Jun Kim, Hyo‐Wook Gil · 2013 · Soonchunhyang Medical Science
  31. Drug-Eluting Stents in Patients With ESRD on Dialysis: A Small Step Forward
    Khaled M. Ziada, Ahmed Abdel‐Latif · 2009 · American Journal of Kidney Diseases
  32. Chapter 12: Cardiovascular Disease in the Elderly With Kidney Disease
    Wolfgang C. Winkelmayer­ · 2009
  33. Acute coronary syndrome and renal dysfunction
    Farid Ismagilievich Belyalov · 2016 · Rational Pharmacotherapy in Cardiology
  34. Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery
    Amit Patel, Sripal Bangalore · 2017 · Springer eBooks
  35. ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKD
    Michael J. Koren, Michael H. Davidson, Daniel J. Wilson, Rana S. Fayyad, Andrea L. Zuckerman, David P. Reed · 2009
  36. Original Investigation Secular Trends in Cardiovascular Mortality Rates of Patients Receiving Dialysis Compared With the General Population
    Matthew A. Roberts, Kevan Roy Polkinghorne, Stephen McDonald, Francesco L. Ierino · 2011
  37. Coronary Intervention in the Chronic Kidney Disease, Diabetic and Elderly Populations
    Sami A. Omar, Osama Alsanjari, Adam de Belder · 2018 · Springer eBooks
  38. Kidney Disease and Medications
    Wolfgang C. Winkelmayer­ · 2010 · Elsevier eBooks
  39. Impact of Renal Impairment on Coronary Vasculature among Patients Undergoing Primary Percutaneous Coronary Intervention and its Effect on Hospital Stay Outcome
    MAHMOUD M. KHALIL, M.Sc. MEDHAT M. ASHMAWY, M.D., Mohammed Elsetiha · 2018 · The Medical Journal of Cairo University/The Medical Journal of Cairo University
  40. Preoperative Cardiovascular Evaluation and Management
    Krista L. Lentine, Todd C. Villines, Kevin C. Abbott, Salvatore P. Costa · 2014 · Springer eBooks
  41. GRADE-Leitlinien zu Gerechtigkeit 3: Berücksichtigung der Gerechtigkeit im Gesundheitswesen bei der Entwicklung von GRADE-Leitlinien: Vertrauenswürdigkeit der Evidenz beurteilen
    Agnes Ebenberger, Barbara Nußbaumer-Streit, Birgit Teufer, Gero Langer, Lukas Schwingshackl, Ingrid Toews, Gerald Gartlehner · 2020 · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen
  42. Approach to Revascularization in the Potential Kidney Transplant Recipient
    Gustavo Soares Guandalini, Sripal Bangalore · 2020 · Springer eBooks
  43. Comment on “Single Versus Multiple Arterial Revascularization in Patients With Reduced Renal Function Long-Term Outcome Comparisons in 23,406 CABG Patients From Ontario, Canada”
    Ilias P. Doulamis, David Blitzer · 2020 · Annals of Surgery
  44. Cardiac Consultative Approach to Hemodialysis Patients and Cardiovascular Evaluation and Management of Potential Kidney Transplant Recipients
    Mengistu A. Simegn, Charles A. Herzog · 2020 · Springer eBooks
  45. Efeito da filtração glomerular em pacientes diabéticos com doença arterial coronariana submetidos aos tratamentos cirúrgico, percutâneo ou clínico: dez anos de seguimento
    Daniel Valente Batista · 2020
  46. Prevention and management of cardiovascular disease in kidney disease and kidney failure
    Pranav Sandilya Garimella, Daniel E. Weiner, Mark J. Sarnak · 2021 · Elsevier eBooks
  47. Anticoagulation Therapy in Patients with Chronic Kidney Disease
    Fatemeh Saheb Sharif‐Askari, Syed Azhar Syed Sulaiman, Narjes Saheb Sharif‐Askari · 2015 · Advances in experimental medicine and biology
  48. New Advances in Cardiorenal Syndrome—Ready for Prime Time?
    Rainer Ullrich Pliquett · 2022 · Journal of Clinical Medicine
  49. Prognostic Impact of Guideline-Directed Medical Therapy in Patients with Heart Failure on Regular Hemodialysis
    Makoto Kishihara, Takuma Takada, Kentaro Jujo, Shota Shirotani, Takuro Abe, Ayano Yoshida, Shonosuke Watanabe, Nobuhisa Hagiwara · 2022 · SSRN Electronic Journal
  50. Prognostic Impact of Guideline-Directed Medical Therapy in Patients with Heart Failure on Regular Hemodialysis
    Makoto Kishihara, Takuma Takada, Kentaro Jujo, Shota Shirotani, Takuro Abe, Ayano Yoshida, Shonosuke Watanabe, Nobuhisa Hagiwara · 2022 · International Journal of Cardiology
  51. A feasibility study for a new one-day protocol for [99mTc]TcDTPA2- and [99mTc]TcDMSA2- renal scintigraphy on dilated and non-dilated pediatric patients: underlying rationale
    Fabiana Trevisan, Beatriz Nascimento, Gabriel Chibana, Luciana Maeda, Marta M. D. C. Vila, Valquíria Miwa Hanai‐Yoshida, Norberto Aranha, Victor M. Balcão, José Martins de Oliveira · 2023 · Brazilian Journal of Radiation Sciences
  52. Avaliação da agregabilidade plaquetária e níveis plasmáticos de adenosina em pacientes com doença arterial coronária estável e doença renal crônica em regime de dupla antiagregação plaquetária com ácido acetilsalicílico em associação com clopidogrel ou ticagrelor
    André Franci · 2024
  53. Overcoming Renalism: A Roadmap Towards Equitable Kidney Care
    Smita Subhash Divyaveer, Urmila Anandh, Niranjan Anitha Vijayakumar, Vaishnavi Venkatasubramanian, Swapnil S. Hiremath · 2025 · Indian Journal of Nephrology
  54. Additional file 2 of Designing a tool ensuring older patients the right medication at the right time after discharge from hospital– the first step in a participatory design process
    Thorbjørn Hougaard Mikkelsen, Søndergaard, Jens, Kjær, Niels Kristian, Jesper Bo Nielsen, Ryg, Jesper, Lene Juel Kjeldsen, Christian Backer Mogensen · 2024 · Figshare
  55. Additional file 1 of Designing a tool ensuring older patients the right medication at the right time after discharge from hospital– the first step in a participatory design process
    Thorbjørn Hougaard Mikkelsen, Søndergaard, Jens, Kjær, Niels Kristian, Jesper Bo Nielsen, Ryg, Jesper, Lene Juel Kjeldsen, Christian Backer Mogensen · 2024 · Figshare
  56. Additional file 6 of Designing a tool ensuring older patients the right medication at the right time after discharge from hospital– the first step in a participatory design process
    Thorbjørn Hougaard Mikkelsen, Søndergaard, Jens, Kjær, Niels Kristian, Jesper Bo Nielsen, Ryg, Jesper, Lene Juel Kjeldsen, Christian Backer Mogensen · 2024 · Figshare
  57. Additional file 1 of Association between baseline LDL-C and prognosis among patients with coronary artery disease and advanced kidney disease
    Wang, Bo, S Q Chen, Liu, Jin, Liang, Yan, Liangguang Meng, Yan, Xiaoming, Huang, Haozhang, Chen, Guanzhong, Huang, Zhidong, Xu, Danyuan et al. · 2021 · Figshare
  58. Additional file 4 of Designing a tool ensuring older patients the right medication at the right time after discharge from hospital– the first step in a participatory design process
    Thorbjørn Hougaard Mikkelsen, Søndergaard, Jens, Kjær, Niels Kristian, Jesper Bo Nielsen, Ryg, Jesper, Lene Juel Kjeldsen, Christian Backer Mogensen · 2024 · Figshare
  59. Additional file 8 of Designing a tool ensuring older patients the right medication at the right time after discharge from hospital– the first step in a participatory design process
    Thorbjørn Hougaard Mikkelsen, Søndergaard, Jens, Kjær, Niels Kristian, Jesper Bo Nielsen, Ryg, Jesper, Lene Juel Kjeldsen, Christian Backer Mogensen · 2024 · Figshare
  60. Additional file 1 of Handling polypharmacy –a qualitative study using focus group interviews with older patients, their relatives, and healthcare professionals
    Thorbjørn Hougaard Mikkelsen, Søndergaard, Jens, Kjaer, Niels Kristian, Jesper Bo Nielsen, Ryg, Jesper, Lene Juel Kjeldsen, Christian Backer Mogensen · 2023 · Figshare
  61. Additional file 1 of Multimorbidity impacts cardiovascular disease risk following percutaneous coronary intervention: latent class analysis of the Melbourne Interventional Group (MIG) registry
    Chau Le Bao Ho, S. Si, Angela Brennan, Tom G Briffa, Stub, Dion, Andrew Edward Ajani, Christopher Michael Reid · 2024 · Figshare
  62. Additional file 5 of Designing a tool ensuring older patients the right medication at the right time after discharge from hospital– the first step in a participatory design process
    Thorbjørn Hougaard Mikkelsen, Søndergaard, Jens, Kjær, Niels Kristian, Jesper Bo Nielsen, Ryg, Jesper, Lene Juel Kjeldsen, Christian Backer Mogensen · 2024 · Figshare
  63. Additional file 7 of Designing a tool ensuring older patients the right medication at the right time after discharge from hospital– the first step in a participatory design process
    Thorbjørn Hougaard Mikkelsen, Søndergaard, Jens, Kjær, Niels Kristian, Jesper Bo Nielsen, Ryg, Jesper, Lene Juel Kjeldsen, Christian Backer Mogensen · 2024 · Figshare
  64. Additional file 3 of Designing a tool ensuring older patients the right medication at the right time after discharge from hospital– the first step in a participatory design process
    Thorbjørn Hougaard Mikkelsen, Søndergaard, Jens, Kjær, Niels Kristian, Jesper Bo Nielsen, Ryg, Jesper, Lene Juel Kjeldsen, Christian Backer Mogensen · 2024 · Figshare
  65. Prognostic impact of chronic kidney disease in patients with atrial fibrillation after percutaneous coronary intervention
    Hiroaki Yaginuma, Hideki Kitahara, Sakuramaru Suzuki, Yuji Ohno, Junya Harada, Kenichi Fukushima, Tatsuhiko Asano, Naoki Ishio, Raita Uchiyama, Hirofumi Miyahara et al. · 2026 · Journal of Cardiology
  66. Mécanismes impliqués dans le remodelage artériel associé à la maladie rénale chronique
    Anne‐Sophie Garnier · 2023
  67. Coronary Artery Disease In Maintenance Hemodialysis Patients: Are We Acting Too Late?
    Jorge Paulo Strogoff de Matos, Jocemir Ronaldo Lugon · 2026 · International Journal of Cardiovascular Sciences
  68. Coronary artery disease treatment strategies and long-term renal function: rationale and design of the cardiorenal study
    Ezio De Martino Neto, Whady Armindo Hueb, Paulo Cury Rezende, Lucas B. De Morais, Eduardo Gomes Lima, Paulo Rogério Soares, Fabio Antonio Venancio, Maria Stanislavovna Tairova, Giovana Outuki, Izabela Jacob Martins et al. · 2026 · International Journal of Clinical Trials
  69. Parkinson’s disease and chronic kidney disease trends and disparities in the US population aged over 25 years (1999–2023)
    Raymond Haward, Nikhil Duseja, Harkanwar Sandhu, Shankar Biswas, Jai Kumar Rajavoor Muniswamy, Mobeen Abid, Pooja Prasad, Newton Ashish Shah, Rutvik Jadvani, Iswariya Mani et al. · 2026 · Medicine
  70. Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals
    Emma O’Lone, Martin Howell, Andrea Katharina Viecelli, Jonathan C. Craig, Allison Tong, Bénédicte Sautenet, William Guy Herrington, Charles A Herzog, Tazeen H Jafar, Meg Jardine et al. · 2020 · Nephrology Dialysis Transplantation
  71. Prevention and Management of Cardiovascular Disease in Kidney Disease and Kidney Failure
    Pranav Sandilya Garimella, Daniel E. Weiner, Mark J. Sarnak · 2012 · Elsevier eBooks